|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | (2006.01) |
| (11) | Number of the document | 3524598 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19150922.3 |
| Date of filing the European patent application | 2013-08-08 | |
| (97) | Date of publication of the European application | 2019-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261681484 P | 2012-08-09 | US |
| (72) |
COHEN, Benjamin M. , US
TRAVERSE, John Fitzgerald , US
XU, Jean , US
LI, Ying , US
|
| (73) |
Celgene Corporation ,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | A SOLID FORM OF (S)-3-(4-((4-MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE HYDROCHLORIDE |
| A SOLID FORM OF (S)-3-(4-((4-MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE HYDROCHLORIDE |